Δρ Χλόη Κωνσταντίνου

ΙΑΤΡΟΣ – ΟΓΚΟΠΛΑΣΤΙΚΟΣ ΧΕΙΡΟΥΡΓΟΣ ΜΑΣΤΟΥ

Χλόη Κωνσταντίνου
Ειδικός Ογκοπλαστικός Χειρούργος Μαστού, MD, PhD
Royal Free Hospital NHS Foundation Trust
London, U.K.

Πλήρες βιογραφικό στα Ελληνικά

Παρούσα θέση:

Ογκοπλαστικός Χειρούργος Μαστού, Royal Free Hospital NHS Foundation Trust London, U.K

Εξειδικευμένη εκπαίδευση στην χειρουργική μαστού

Αύγουστος 2016-Ιούλιος 2017

Μονάδα Μαστού Royal Marsden Hospital London NHS Foundation Trust: Εντατικό fellowship στην Ογκοπλαστική Χειρουργική του Μαστού.

Μάρτιος 2013-Ιούλιος 2016

Μονάδα Μαστού του Royal Free London NHS Foundation Trust: Fellowship στη Χειρουργική Μαστού.

Δεκέμβριος 2012-Μάρτιος 2013

Μονάδα Μαστού του Imperial College Healthcare NHS Trust Charing Cross and St Mary’s Hospital: Fellowship στη Χειρουργική Μαστού.

Ιούλιος 2011-Απρίλιος 2012

Μονάδα Μαστού στο ιδιωτικό Γενικό Νοσοκομείο Υγεία:: Χειρουργός Μαστού.

Ιανουάριος 2011-Ιούνιος 2011

Μονάδα Μαστού του Imperial College Healthcare NHS Trust St Mary’s Hospital: Honorary Fellowship στη Χειρουργική Μαστού.

Οκτώβριος 2010- Δεκέμβριος 2010

Μονάδα Μαστού της A’ Χειρουργικής και Γυναικολογικής Κλινικής του Νοσοκομείου Έλενα Βενιζέλου Αθήνα, Ελλάς: Κλινική Μετεκπαίδευση στη Μονάδα Μαστού.

Εκπαίδευση

Γενική Χειρουργική:Μάρτιος 2005-Απρίλιος 2011

Κοργιαλενιο-Μπενάκειο Ε.Ε.Σ. Γενικό Νοσοκομείο Αθηνών

Πτυχίο Ιατρικής:1997-2003

Πανεπιστήμιο Ιωαννίνων με βαθμό 8/10.

PhD:

Ιατρική Σχολή Πανεπιστημίου Ιωαννίνων με βαθμό Άριστα

Θέμα: “Expression and Clinical Significance of claudin-7, PDL-1, PTEN, c-Kit, c-Met, c-Myc, ALK, CK5/6, CK17, p53, EGFR, Ki67, p63 in Triple Negative Breast Cancer. A Single Centre Prospective Observational Study.”

Full CV

Summary

After spending my summers as a medical student in the Major Anticancer Centre in Athens “Agios Savvas” and rotating among different surgical specialties I was fascinated by breast surgery. Even before I completed my general surgical training in 2011 I was accepted for a 6 months Honorary Fellowship at the Breast Unit of St Mary’s hospital, London and since then I have been dedicated to improve my skills in the management of breast cancer including diagnosis adequate follow up of patients, oncoplastic surgery and reconstruction. I have completed three fellowships in Breast Surgery in the Breast Unit of Imperial College Healthcare NHS Trust, in the Breast Unit of Royal Free London NHS Foundation Trust and the year 2016 I completed a one year intensive fellowship in Oncoplastic Breast Surgery at the Royal Marsden Hospital. During these posts I was organising and managing Outpatient Breast clinics, where I felt very valuable to patients and often acted as advocate, confidante and occasional counsellor. I have also contributed and gained insight into all areas of the job from attending multi-disciplinary meetings, presenting and organising Oncoplastic MDT and being able to perform all range of operations in breast surgical oncology as well as various techniques in breast reconstruction in very complicated patients. I was also involved in many activities of clinical governance as, organising and presenting in the weekly journal club, preparing audit proposals for the two national audits IBRA2 and TEAM study.

The feedback and the love that I receive from my patients is incredible not only in the form of Thank you cards but also with many compliments to PALS, direct emails to the chief executive and also 5/5 online reviews to the site “IWANTAGREATCARE”

With regards of teaching I am supervising and teaching the junior doctors as well the medical students.

With regards of service development and improvement Ι have organised and became the clinical lead for the presentations of the M&M, I have also been appointed as Clinical Governance and Audit Lead.

Academically I have completed my PhD research on Triple Negative Breast cancer patients and the paper with the results have been published IN VIVO journal on PUBMED. I defended my thesis December 2018 and passed with distinction. This was a retroprospective project that investigated the correlation of immnunohistochemical markers with the prognosis of triple negative breast cancer.

I have also published scientific papers to peer review journals and I had the opportunity to collaborate in research with Professor Ian Fentiman.

Education

2005-2011: Korialenio Mpenakio E.E.S Athens General Hospital: General Surgery Residency Program. (6-year program including Basic Surgery Training, Accident and Emergency and advance SpR Training in General Surgery with specialties rotation).

1997-2003: “Doctor of General Medicine” (MBBS equivalent), University of Ioannina. Graduate with the degree “Very Good” (8/10)

Surgical training

August 2016-July 2017 Breast Unit Royal Marsden Hospital London NHS Foundation Trust: Oncoplastic Fellowship in Breast Surgery
March 2013-July 2016 Breast Unit Royal Free London NHS Foundation Trust: Fellowship in Breast Surgery
December 2012-March 2013 Breast Unit Imperial College Healthcare NHS Trust Charing Cross and St Mary’s Hospital: Fellowship in Breast Surgery
July 2011-April 2012 Breast Unit, Hygeia Private hospital, Athens, Greece: Associated Surgeon
January 2011-June 2011 Breast Unit Imperial College Healthcare NHS Trust St Mary’s Hospital: Honorary Fellowship in Breast Surgery
October 2010- December 2010 Breast Unit at the A’ Surgical and obstetric Clinic ‘”Elena Venizelou” hospital Athens, Greece: Clinical Fellow in the Breast Unit
March 2005-April 2011 Korialenio Mpenakio E.E.S Athens General Hospital: General Surgery Residency Program. (6-year program including Basic Surgery Training, Accident and Emergency and advance Training in General Surgery with specialties rotation).

PhD

University of Ioannina, School of Medicine Greece

Completion Date: December 2018-passed with distinction

“Expression and Clinical Significance of claudin-7, PDL-1, PTEN, c-Kit, c-Met, c-Myc, ALK, CK5/6, CK17, p53, EGFR, Ki67, p63 in Triple Negative Breast Cancer. A Single Centre Prospective Observational Study”

Publications:

Expression and Clinical Significance of claudin-7, PDL-1, PTEN, c-Kit, c-Met, c-Myc, ALK, CK5/6, CK17, p53, EGFR, Ki67, p63 in Triple Negative Breast Cancer. A Single Centre Prospective Observational Study C Constantinou, S Papadopoulos, E Karyda, A Alexopoulos, N Agnanti, A Batistatou and H Harisis in vivo32: 303-311 (2018) doi:10.21873/invivo.11238
Inflammation and breast cancer.C Constantinou, IS Fentiman Breast Cancer Management, 2013 Vol. 2, No. 4, Pages 311-325, DOI 10.2217/bmt.13.26 (doi:10.2217/bmt.13.26)
Ductal Carcinoma in Situ Treatment Requires a Multidisciplinary Approach. C Constantinou, IS Fentiman Journal of Cancer Therapy 2013 Vol. 4 No. 7, Article ID: 36240 , 14 pages DOI:10.4236/jct.2013.47140
The value of plasma neurotensin and cytokine measurement for the detection of bowel ischaemia in clinically doubtful cases: a prospective study. Sgourakis G, Papapanagiotou A, Kontovounisios C, Karamouzis MV, Lanitis S, Konstantinou C, Karaliotas C, Papavassiliou AG.Exp Biol Med (Maywood).
Diagnosis and treatment of Male Breast Cancer. Chloe Constantinou and Ian Fentiman Breast cancer Management, 2013 Vol. 1, No. 4, Pages 295-304 , DOI 10.2217/bmt.12.47 (doi:10.2217/bmt.12.47)
Laparoscopic Cholecystecomy: Coming of age in Greece. Retrospective clinical study. D. Ntourakis, E.Kritikos, E. Tsovolou, Ch.Konstantinou, Ch. Tampakis, I. Stavrakis, P. Tzardis. Hellenic Journal of Surgery 2010; 82: 1

Collaborator:

The TeaM study 2017
The iBra-2 study 2017
Current margin practice and effect on re-excision rates following the publication of the SSO-ASTRO consensus and ABS consensus guidelines: a national prospective study of 2858 women undergoing breast conserving therapy in the UK and Ireland

Academic Distinctions and Awards

5/2002 Award from the Histopathological department, Ioannina Medical University, for the best scientific performance for the year 2002

National/International Courses

Oncoplastic And Reconstructive Breast Surgery International Scientific Meeting, (ORBS Meetings) 30 September to 2nd October 2019
1^st UK Interdisciplinary Breast Cancer Symposium held on 15^th-16^th January 2018 at Manchester Central Convention Centre
Innovations and Advances in Breast Surgery (IABS)-First International Conference held at Wolverhampton University 26^th June 2017
2^nd Integra Interantional Tissue Technologies symposium June 15-16^th ,2017 Berlin Germany
Association of Breast Surgery Conference 15^th and 16^th May 2017 Belfast Waterfront.
Oxford Oncoplastic Breast Surgery (OOPS) Course. (16th-17th March 2017)
Trainning the Trainners of today module 1 and 2, 10th February 2017
4th ABS Multidisciplinary Meeting 2017
The Royal Marsden Hospital management course Management course 2days 2016
The 19^thEducational day for Breast Cancer, Helenic Breast Surgical Society 15/10/2016
The 9^th annual Royal Marsden Breast Cancer Meeting Friday 7/10/2016
Allergan’s Medical Institute Surgeon’s Day, 24/09/2016, London
Specialty skills in Breast Surgery: Principles in Breast reconstruction Level 2 at The Royal college of Surgeons of England 26-27/5/2016
Preparing for your first consultant role. MDU-Management course 03/03/2016 London
Surgical Aesthetics Educational Day, 27/02/2016, London
ESSO Advanced Course on Breast Cancer Surgery Lisbon 08-10/10/2014
Breast reconstruction with ADM Kings College July 2014
TARGIT Academy Training Course UCL February 2014 London
Advanced Trauma Life Support. 2007- University of Athens
Basic Life Support. 2007 University of Athens

Facebook Tweet Pin LinkedIn